Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema
This study has been terminated.
( occurrence of retinal hemorrhage , increase in macular edema of some patients in TPA group )
Study NCT01141881   Information provided by Mashhad University of Medical Sciences

First Received on June 10, 2010.   Last Updated on October 7, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Macular Edema
Additional conditions recognized in this trial
Edema
Macular Edema
More general conditions related to this trial
Eye Diseases
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Additional drug interventions recognized in this trial
Bevacizumab
Plasminogen
Tissue Plasminogen Activator
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Growth Inhibitors
Growth Substances
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mashhad University of Medical Sciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services